These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17381445)

  • 1. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study.
    Cunnington M; Ferber S; Quartey G;
    Epilepsia; 2007 Jun; 48(6):1207-10. PubMed ID: 17381445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results on pregnancy outcomes in women using lamotrigine.
    Tennis P; Eldridge RR;
    Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final results from 18 years of the International Lamotrigine Pregnancy Registry.
    Cunnington MC; Weil JG; Messenheimer JA; Ferber S; Yerby M; Tennis P
    Neurology; 2011 May; 76(21):1817-23. PubMed ID: 21606453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Lamotrigine pregnancy registry update for the epilepsy foundation.
    Cunnington MC
    Epilepsia; 2004 Nov; 45(11):1468. PubMed ID: 15509254
    [No Abstract]   [Full Text] [Related]  

  • 6. Lamotrigine and the risk of malformations in pregnancy.
    Cunnington M; Tennis P;
    Neurology; 2005 Mar; 64(6):955-60. PubMed ID: 15781807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The teratogenic risk of antiepileptic drug polytherapy.
    Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
    Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer-generation antiepileptic drugs and the risk of major birth defects.
    Mølgaard-Nielsen D; Hviid A
    JAMA; 2011 May; 305(19):1996-2002. PubMed ID: 21586715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EURAP: an international registry of antiepileptic drugs and pregnancy.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Vajda F;
    Epilepsia; 2004 Nov; 45(11):1463-4. PubMed ID: 15509250
    [No Abstract]   [Full Text] [Related]  

  • 13. Australian pregnancy registry of women taking antiepileptic drugs.
    Vajda F; Lander C; O'brien T; Hitchcock A; Graham J; Solinas C; Eadie M; Cook M
    Epilepsia; 2004 Nov; 45(11):1466. PubMed ID: 15509252
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiepileptic drug regimens and major congenital abnormalities in the offspring.
    Samrén EB; van Duijn CM; Christiaens GC; Hofman A; Lindhout D
    Ann Neurol; 1999 Nov; 46(5):739-46. PubMed ID: 10553991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy registries in epilepsy.
    Beghi E; Annegers JF;
    Epilepsia; 2001 Nov; 42(11):1422-5. PubMed ID: 11879345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.
    Reiff-Eldridge R; Heffner CR; Ephross SA; Tennis PS; White AD; Andrews EB
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):159-63. PubMed ID: 10649172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.
    Dolk H; Wang H; Loane M; Morris J; Garne E; Addor MC; Arriola L; Bakker M; Barisic I; Doray B; Gatt M; Kallen K; Khoshnood B; Klungsoyr K; Lahesmaa-Korpinen AM; Latos-Bielenska A; Mejnartowicz JP; Nelen V; Neville A; O'Mahony M; Pierini A; Rißmann A; Tucker D; Wellesley D; Wiesel A; de Jong-van den Berg LT
    Neurology; 2016 May; 86(18):1716-25. PubMed ID: 27053714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
    Dolk H; Jentink J; Loane M; Morris J; de Jong-van den Berg LT;
    Neurology; 2008 Sep; 71(10):714-22. PubMed ID: 18650491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy and pregnancy: lamotrigine as main drug used.
    Sabers A; Dam M; A-Rogvi-Hansen B; Boas J; Sidenius P; Laue Friis M; Alving J; Dahl M; Ankerhus J; Mouritzen Dam A
    Acta Neurol Scand; 2004 Jan; 109(1):9-13. PubMed ID: 14653845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.